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Doing patient-centredness versus achieving public health targets: A 
critical review of interactional dilemmas in ART adherence support.  
 
Abstract 
Anti-retroviral Therapy (ART) transformed HIV into a chronic disease but its individual and 
public health benefits depend on high levels of adherence.  The large and rising number of 
people on ART, now also used as prevention, puts considerable strain on health systems and 
providers in low and middle as well as high-income countries, which are our focus here.  
Delivering effective adherence support is thus crucial but challenging, especially given the 
promotion of patient-centredness and shared decision making in HIV care. To illuminate the 
complexities of ART adherence support delivered in and through clinical encounters, we 
conducted a multi-disciplinary interpretative literature review. We reviewed and synthesized 
82 papers published post 1997 (when ART was introduced) belonging to three bodies of 
literature: public health and psychological studies of ART communication; anthropological 
and sociological studies of ART; and conversation analytic studies of patient-centredness and 
shared decision-making. We propose three inter-related tensions which make patient-
centredness particularly complex in this infectious disease context: achieving trust versus 
probing about adherence; patient-centredness versus reaching public health targets; and 
empowerment versus responsibilisation as ‘therapeutic citizens’. However, there is a dearth of 
evidence concerning how precisely ART providers implement patient-centredness, shared-
decision making in practice, and enact trust and therapeutic citizenship. We show how 
conversation analysis could lead to new, actionable insights in this respect. 
 
Key-words: Patient-centredness; shared decision-making; therapeutic citizenship; HIV; ART; 
adherence; adherence support; conversation analysis 
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1. Introduction 
 
HIV is an infectious disease of major global importance, which was transformed in the late 
1990s from a deadly to a chronic disease by the advent of anti-retroviral therapy (ART).  
Globally, the number of people on ART is now large (19.5 million in 2016), and still rising in 
low, middle and high income settings (UNAIDS, 2017), the latter of which is our focus here. 
The rise is partly due to a shift in guidelines: clients should now commence life-long ART 
when diagnosed and ‘ready’ for treatment, whatever their CD4 count (WHO, 2016). 
Moreover, evidence that ART can prevent onward transmission has led to ‘treatment as 
prevention’ (TasP) and pre-exposure prohylaxis (PrEP) approaches (Yin et al., 2014).  
Despite controversy (Kelen & Cresswell, 2017), PrEP is now offered to those at substantial 
risk of exposure, including ‘key populations’ (Men who have Sex with Men, MSM; sex 
workers), sero-discordant couples (where only one partner is HIV positive), and pregnant 
women (WHO, 2016).  
  As a result, ART takes up considerable resources and places an increasing burden on 
already constrained health systems and providers. One contribution to this pressure is the need 
for continuous monitoring and support of ART adherence (BHIVA, 2016; WHO, 2016). 
Suboptimal adherence can lead to drug resistance, thereby threatening the drugs’ individual 
and public health (and economic) benefits. Hence, adherence has been called the ‘Achilles 
heel’ of ART (Nachega et al., 2014). A significant minority of clients do not achieve optimal 
adherence (Mills et al., 2006a; Kirwan et al., 2016). For example, even in a relatively high 
performing country like the UK, approximately 10% of HIV infected people have a viral load 
associated with life-threatening risks to the individual and wider public (Nachega et al., 2014; 
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Kirwan et al., 2016). Moreover, vulnerable groups such as people under 25, the less affluent, 
prisoners and substance misusers, have lower adherence levels (BHIVA, 2016; Kirwan et al., 
2014). PrEP has extended concerns about suboptimal adherence to people at risk of 
contracting HIV (Gupta et al., 2013). Thus, high quality HIV adherence support is a health 
policy priority, and a recognized challenge given that clients are increasing in number, but 
also age and diversity (Scottish Government 2009; WHO, 2016).  
Adherence support can be delivered in the community or clinic; in this paper, we 
focus on professional adherence support, delivered in the clinical encounter (de Bruin et al., 
2010a, b). The clinical encounter, and more specifically, the provider-client relationship, has 
been identified as one of the correlates of adherence, alongside other factors relating to the 
client (e.g. health status; illness beliefs); the treatment regime (complexity, side-effects), and 
the socio-economic and health system context (poverty, access) (Ammassari et al., 2002; 
Ickovics & Meade, 2002; Vervoort, Borleffs, Hoepelman, & Grypdonck, 2007).  We seek to 
illuminate the role of provider-client relationships and communication as key areas of 
adherence support, and in particular the roles of patient-centredness and shared decision-
making. These have been dominant health paradigms in high income settings since the 1990s, 
are part of global (WHO, 2016) and national (BHIVA, 2016) HIV policies, and have a direct, 
significant and recognised bearing on interaction (BHIVA, 2016). Patient-centredness places 
the patient’s feelings and preferences at the heart of the consultation and treatment decisions 
(Stewart, 2001); shared decision-making is similarly characterised by basing decisions on 
patients’ values or preferences, and by providing options and establishing partnerships 
(Makoul & Clayman, 2006). These approaches entail a shift away from a paternalistic focus 
on achieving compliance with providers’ instructions to the pursuit of concordance and 
respect for clients’ autonomy and informed choice, even if this entails treatment rejection 
(Kremer, Bader, O’Cleirigh, Bierhoff & Brockmeyer, 2004).  Reasons for the shift include 
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cost-effectiveness; some evidence suggests that shared decision-making enhances treatment 
adherence and health outcomes (Coulter, 1997; Matthias, Salyers & Frankel, 2013). However, 
the evidence is not unequivocal and the shift is also ideological: treating patients and 
professionals as equals is seen as a moral ‘good’ (Pilnick & Dingwall 2011).  
However, patient-centredness and shared decision-making merit more critical 
reflection.  For example, Mol (2008) argued that the ‘logic of choice’ underpinning shared 
decision-making is an overly rationalistic approach, promulgated by western neo-liberal 
ideals which celebrate autonomy, but which does not necessarily constitute ‘good’ care. 
Others have argued against a ‘one size fits all’ model; whether and how patient-centredness 
and shared decision-making principles work in practice should be examined within specific 
socio-cultural, health system and disease contexts (Matthias, Salyers & Frankel, 2013; Pilnick 
& Zayts, 2015). Pilnick and Dingwall (2011) have critiqued the universal pursuit of patient-
centredness, arguing that asymmetry may simply be endemic to the medical enterprise given 
the professionals’ greater medical expertise, and it may ultimately be our view of this 
asymmetry that is problematic rather than its continued presence. 
  To date, most studies examining and supporting patient-centredness and shared 
decision-making have focused on diseases for which several alternative management options 
exist (e.g. diabetes, cancer), and where patients’ views about treatment can be given 
precedence without the possibility of causing wider harms to public health. The situation is 
rather different in the context of infectious diseases such as HIV. Here, patients’ decisions not 
to follow treatment advice may have particularly large public health consequences. Therefore, 
we seek to unpack the complexities of patient-centred care and shared decision-making in 
adherence support in the HIV context, and address the following questions. What is the 
relationship between ART adherence and provider-patient communication, in particular 
patient-centeredness and shared decision-making, in high income countries? How, if at all, are 
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patient-centeredness and shared decision-making put into practice in ART adherence support 
provided in the clinical encounter? We will show how ethnographic studies can aid our 
understanding of the complexities and dilemmas involved and we propose that conversation 
analysis (CA) can provide an empirical understanding of how these dilemmas play out in 
practice. 
We base our arguments on a multi-disciplinary systematic literature review guided by 
principles of critical interpretative synthesis (Dixon-Woods et al., 2006), the details of which 
we present below.  
  
2. Methodology 
 
Critical interpretative synthesis (CIS; Dixon-Woods et al., 2005) is an iterative form of review 
which seeks to develop theoretical and empirically grounded understandings of a 
phenomenon through critical interpretation and synthesis of diverse bodies of quantitative and 
qualitative literature. We combined an aggregative review (summarizing existing knowledge), 
with an interpretative review (developing new interpretations) (Gough, Thomas, & Oliver, 
2012).  
 
Search strategy 
We reviewed three separate ‘sets’ of literature, identified through different search and 
selection strategies informed by emerging insights, in keeping with CIS principles (Dixon-
Woods et al., 2006). We started with set 1: empirical studies of the relationship between ART 
adherence and provider-client interaction and relationships in high income settings, mostly 
produced by psychologists and public health experts, and mostly focused on the US. This set 
(N=44) was generated by a systematic search, using key words (Table 1) to search databases 
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(CINAHL, PubMed, MEDLINE, PsychINFO and Scopus) in 2012, 2014 and 2017. Search 
terms were adjusted after an initial search and screening of titles and abstracts (e.g. we added 
‘antiretroviral’ to ‘ART OR ARV’).  
 
INSERT Table 1. Keywords (in abstracts).  
 
Findings regarding the complexity and sensitivity of adherence talk drew our attention 
to set 2, the predominantly ethnographic anthropological and sociological literature which 
theorizes ART, its social and moral dimensions and its impact on identities and relationships. 
Studies of therapeutic citizenship (Nguyen, 2004, 2005) were particularly key here. These 
papers (N=10) were identified through snowball sampling, starting from Nguyen’s (2004) 
seminal publication. They helped to interpret and conceptualise the empirical findings from 
set 1. 
Third, our review indicated that the analysis of actual clinical encounters was highly 
relevant but largely absent in both sets; we therefore turned to conversation analytic (CA) 
studies. These use recorded interactions to examine patient-centredness and shared decision-
making. Snowball sampling was again used for this third set (N= 28) to explore the potential 
contribution of this kind of analysis to our emerging understanding of challenges in adherence 
support.  
 
In- and exclusion 
We included English language publications after 1997, when highly active ARVs (HAART) 
were introduced.  All study designs, types of health providers (e.g. pharmacists) and clients 
(e.g. children, prisoners) were eligible for inclusion. We excluded studies from low and 
middle income countries (LMICs) in set 1 because our interest was in assessing current 
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knowledge regarding the role of provider-client relationships and communication in ART 
adherence in high income settings.  However, in set 2, we did include studies from LMICs, as 
this is where most ethnographic research is conducted, and we used this set to develop 
theoretical insights and arguments rather than to synthesize empirical findings. Theoretical 
insights emerging from studies conducted in LMICs are likely transferable to high income 
countries (HICs), although this requires further assessment through empirical studies. 
Virtually all CA studies are conducted in HICs, but set 3 also included a few studies from 
LMICs, which were relevant since our purpose was to demonstrate the kinds of insights the 
methodology of CA could provide into provider-client interaction, patient-centredness and 
shared decision-making. CIS acknowledges that methodologically weak papers may still offer 
conceptual insights and recommends only excluding papers with ‘fatal flaws’ (Dixon-Woods 
et al., 2006), but we did not encounter any in our sample.  
For set 1, a research assistant screened titles and abstracts of papers for relevance and 
applied inclusion and exclusion criteria. The first author read the abstracts and full papers of 
those included and checked a sample of the excluded papers to ensure agreement on exclusion 
criteria. Papers were excluded usually because they were not written in English, discussed the 
‘art’ of communication but not ART, or addressed ‘interaction’ between ART correlates, not 
provider-client interaction. 
 
Sampling 
The search for set 1 resulted in 194 studies. Following CIS principles (Dixon-Woods et al., 
2004), we sought to be comprehensive but not exhaustive and used purposive (maximum 
variation) and theoretical sampling (Gough, Oliver & Thomas, 2012). For instance, we 
ensured that we selected studies including less common populations (e.g. conducted in 
countries other than US; 100% adherent clients). We applied principles of theoretical 
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saturation: the review of the full papers continued until coherent conclusions emerged from 
the studies reviewed and no substantially new or contradictory insights appeared in other 
studies. Moreover, although the new studies reviewed in 2017 added nuances, alternative 
examples and so on, they reinforced our conclusions and therefore our judgement that we had 
reached a form of saturation and our conclusions were robust. In addition, in set 2, we 
selected studies which provided theoretical insights and tools, such as ‘therapeutic 
citizenship’ which appeared to resonate with, and were able to explain, some of the empirical 
findings reported across several studies. Figure 1 depicts the search results. 
INSERT Figure 1. 
Data extraction and synthesis 
 
For set 1, we used a data-extraction table (exemplified in Supplemental table 1) to record 
primary data (statistics and interview quotes) and the original researchers’ interpretations. We 
used these to develop, with the help of sets 2 and 3, new synthesizing interpretations which 
encompass and go beyond insights from the individual studies (cf. Dixon-Woods et al. 2006). 
For sets 2 and 3 we produced mainly written summaries (like Dixon-Wood et al. 2006), since 
ethnographic studies, reflective commentaries (set 2) and detailed conversation analyses (set 
3) do not lend themselves for systematic ‘data-extraction’. Moreover, we used sets 2 and 3 
mainly to develop our own synthesizing interpretations and arguments (presented in sections 
3.3. and 3.4), rather than for systematic empirical synthesis.  
We first present our synthesis of set 1, and discuss the evidence regarding the 
association between provider-client relationships, communication and adherence (Section 
3.1). We subsequently focus more specifically on the role of patient-centredness and shared 
decision-making (section 3.2). We then discuss the complexities and tensions involved in 
adherence support and use the anthropological and sociological literature from set 2 to further 
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articulate the tensions and interpersonal, moral dilemmas in adherence support and 
communication (3.3). Finally, we discuss how detailed studies of interaction can aid our 
understanding of the enactment of patient-centeredness and shared decision-making in the 
area of HIV/ART (section 3.4). We conclude by highlighting the need for methods which 
allow the examination of actual adherence communication as it happens, rather than post-hoc 
assessments of it. 
  
3. Findings 
3. 1 The role of provider-client relationships and communication in ART adherence. 
 
A number of studies and systematic reviews indicate that provider-client relationships can 
foster or impede adherence (Alfonso et al., 2006, 2009; Atkinson, Schonnesson, Williams & 
Timpson, 2008; Oetzel, Wilcox, Avila Hill, Archipoli & Ginossar, 2015; Schneider, Kaplan, 
Greenfield,  Li, & Wilson,  2004; Van den Berg, Neilands, Mallory, Johnson, Chen, & Saberi, 
2016; Vervoort, Borleffs, Hoepelman & Grypdonck, 2007, Mills et al., 2006a).  The evidence 
is not unequivocal however. Some of the studies included in the systematic review by 
Ammassari and colleagues (2002) did not establish a relationship between the provider-client 
relationship and adherence. In addition, some non-adherent clients report a good relationship 
with their provider (Kremer et al., 2004). 
Communication appears an important dimension of the provider-client relationship 
affecting adherence and, more generally, client satisfaction. First, studies which asked what 
aspects of the provider-client relationship enhance  patient satisfaction, adherence, or both, 
identified features such as providers showing respect (Alfonso et al., 2009; Murri et al., 2002; 
Tugenberg, Ware & Wyatt, 2006; Vervoort et al., 2006); understanding, openness, and 
honesty (Alfonso et al., 2009); a caring attitude and  responsiveness  (Vervoort et al., 2006); 
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‘reflective listening’ (Wilson et al., 2010); and taking time to listen (Vervoort et al., 2006).  
These aspects all relate to communication. Second, providers’ ability to address adherence 
barriers, whether clients’ psychological characteristics (e.g. self-efficacy, ‘treatment 
readiness’), treatment factors (e.g. side effects), or structural issues (e.g. housing, poverty), 
relies on open discussion of these barriers (cf. Mills et al. 2006a). Third, adherence support 
requires accurate assessment of (non) adherence, usually based on a combination of CD4 and 
viral load monitoring, pill counting and self-report (WHO, 2016). However, providers appear 
to commonly over and under-estimate adherence, especially amongst lower educated and 
unemployed clients (Murri et al., 2002). Accuracy of providers’ adherence assessment will 
partly depend on the quality of provider-client communication. 
  Three key features of doctor-patient communication and relationships recur in the 
literature on ART adherence: trust, patient-centredness, and joint decision making. It is 
therefore to the review of these features we now turn. 
 
3.2 Trust, patient-centredness and shared-decision making: Achievable ideals?  
First, trust, which will partly depend on communication features like taking time to listen 
(Vervoort et al., 2006), is found to be a facilitator of adherence in quantitative studies (Altice, 
Mostashari, & Friedland, 2001; Blackstok et al., 2012; Saha et al, 2010) and qualitative and 
mixed-method reviews (Mills et al., 2006; Vervoort et al., 2006). Altice, Mostashari and 
Friedland (2001) found that trust in the provider, and to a lesser extent in the medication and 
medical institution, were correlated with treatment acceptance amongst US prisoners. 
However, Graham, Shahani, Grimes, Hartman and Giordano (2015) found adherence was not 
predicted by trust in physicians nor in the healthcare system among newly diagnosed patients, 
although physician trust was associated with retention in care.  
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  Levels of trust vary per client group, with members of marginalised groups generally 
having lower levels of trust in providers, treatment and institutions (Pach et al., 2003; Saha et 
al., 2010, Siegel et al., 2000). For example, in an interview study with drug users (88% 
African American), some respondents expressed suspicions about being experimented on 
because ‘people don’t like dope friends’ (Pach et al., 2003, p. 92). Distrust may well have 
contributed to the very high non-adherence rate (75%) in this study. Similarly, Gilbert et al. 
(2007, p. 166) asked participants with a history of drug-abuse to complete the prompt ‘When I 
am deciding about taking my HIV medications, I think about . . .’. Several statements 
reflected compromised trust in the government, medical institutions and provider, such as: 
‘Lack of trust when the doctor terminates medications that are working’ (op cit., p. 170).  
Black Americans’ trust in HIV health care providers has been found to be generally lower 
than white clients’, likely related to prior experiences of discrimination in everyday life and 
health care (Saha et al., 2010). 
Second, turning to consider patient-centredness, several studies have found that 
patients’ perception of being known ‘as a person’ (often regarded as key to patient-
centredness) predicts ART adherence (Schneider et al., 2004; Beach, Keruly & Moore, 2006).  
Alfonso et al. (2009, p.122) describe how providers identified a range of patient-centred 
attitudes and behaviours that enhanced communication and trust, including ‘putting 
themselves in the patients’ shoes’, addressing specific needs, treating people as individuals, 
and ‘hearing the whole person and not just the symptoms’. Patients also appreciated 
information being matched to their needs. Hence, patient-centredness may affect adherence 
through other correlates such as trust, or psychological characteristics like health optimism or 
self-efficacy (Atkinson et al., 2008).  
Third, there is also some evidence that shared decision-making is associated with 
adherence, but the evidence is more mixed.  In a qualitative study of German clients who 
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refused treatment (Kremer et al. 2004, p. 66), several clients had felt coerced by their provider 
to take treatment. They critiqued providers’ unilateral decisions and pursuit of compliance 
(e.g. ‘The doctor should not act as a general ordering patients to take pills. Those who do not 
obey are lost. They have nothing to say’). A Swedish survey study (Nilsson Schönnesson, 
Diamond, Ross, Williams & Bratt, 2006) found that perceived pressures from medical staff to 
take HIV medication correlated with reduced adherence. Mills et al.’s (2006b) systematic 
review found some evidence (four studies) that active involvement in treatment decision 
making facilitates adherence, but this was far less strong than for trust (29 studies). Lewis, 
Colbert, Erlen & Meyers (2006) found that a common feature of clients with perfect 
adherence was that they had established an active partnership with their physicians and 
identified themselves as part of the health care team. Alfonso et al. (2009) found that some 
clients reported that collaboration and involvement in treatment decisions was empowering 
and sustained adherence; providers too found this important. However, these two studies 
included non-representative client groups; primarily white and relatively highly educated. 
Active involvement may be a general preference of these client groups, rather than a general 
determinant of adherence, which as Lewis et al. (2006) suggest may have been fostered by 
other factors such as high education levels or cohabitation (providing social support). 
Marelich and Murphy’s (2003) study also point to the variable importance of shared decision-
making; clients who were less ill indicated greater desire to be actively involved in medical 
management.  Finally, in a cross-sectional survey with 554 predominantly white clients, 
Schneider et al. (2004) found that out of seven physician-patient relationship quality 
variables, only participatory decision-making was not significantly associated with ART 
adherence.  
  In summary, evidence suggests that providers and clients commonly deem patient-
centredness and shared decision-making important, in general and for adherence, but there is 
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variation across patient groups. Moreover, most studies rely on cross-sectional surveys or 
interviews; few studies analyse actual interactions. Those that do, suggest a tendency for 
adherence discussions to lack features of patient-centredness and shared-decision making.  
For example, Barfod et al. (2006) observed and took fieldnotes on 183 consultations in the 
USA and Denmark (66% white clients), and interviewed physicians. They found that most 
consultations included adherence discussions, but they lacked depth. The authors identified 
the use of what they described as leading questions (‘you don’t have any problems, do you?’) 
or broad, standard questions rather than individualized ones, often resulting in superficial 
responses of ‘low believability’. Probing was not common, and physicians responded to such 
statements with ‘okaying’ or ‘circumventing dialogue’ , described as continuing the 
discussion without drawing attention to a potential ‘lie’. However, the use of field notes in 
this study means that details of these interactions and the sequential relationship between 
patient and physician talk are not available. Barton Laws and colleagues (2013a, b) analysed 
recorded consultations with 435 patients and 45 providers in the US, and found that providers 
asked mainly what were categorised as closed and leading questions. Providers checked for 
understanding infrequently, asked few questions which elicited values, opinions or 
preferences, and used more ‘directives’ in adherence talk compared to other topics. Clients 
asked fewer questions in these sections of the consultation. ‘Resolution processes’, including 
treatment decisions and problem solving included few expressions of patients’ values or needs 
(Barton Laws et al., 2013b). On the contrary, problem solving often contained directives 
(Wilson et al., 2010), and joint problem solving was uncommon even when patients reported 
adherence problems (Barton Laws et al. 2013a). Callon et al. (2016, p. 1112) found that ‘a 
substantial minority of [US] providers (24 %) did not ask or elicit accurate disclosure 
from patients who were asked’.  
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  Given the observed limitations in depth, space for clients’ questions or expressions of 
needs, and joint problem solving, these observational studies indicate that patient-centredness 
and shared decision-making are not routinely prominent in ART adherence discussions. 
Indeed, clients report that providers prioritise the need to adhere over their choice and 
concerns (Kremer et al. 2003). Similarly, Stevenson et al. (2000) found little evidence that 
patients and general practitioners shared information about, or views on, medicines (not 
specifically ART). Hence, they had no basis on which to share treatment-decisions. 
These are important findings. Despite mixed evidence regarding their causal impact on 
adherence, it is nonetheless clear that clients, providers and policy-makers commonly deem 
patient-centredness important for good relationships and communication, and for adherence. 
It also appears important for client satisfaction (Johnston Roberts 2000; Kremer et al., 2004; 
Okoro & Odedina, 2016), which is crucial given the need to retain clients with HIV in life-
long care (WHO, 2016).   
In the next section we discuss three tensions, or interactional dilemmas, which we 
suggest may limit the space of shared decision-making and patient-centredness in ART 
adherence discussions.  
 
3.3 ART adherence and the clinical encounter: Tensions and morality  
 
We have seen that in addition to trust, patient-centredness and shared decision-making are 
widely regarded as important elements for achieving good adherence and satisfactory 
provider-client support. Yet, evidence regarding their effectiveness and actual implementation 
are mixed. We propose that this ambiguity can be understood in terms of three related 
interactional tensions between conflicting demands: probing versus trust; public health targets 
versus patient-centredness; and responsibilisation versus empowerment. 
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  The first tension arises from the need to maintain trust and to establish whether clients 
have been taking prescribed medication, which requires discussion and probing.  In one study 
(Barfod et al., 2006), providers explained that one reason for limited adherence discussion is 
that they feel awkward about discussing adherence, especially when clients have previously 
reported good adherence, there are no ‘objective’ signs of non-adherence, or the relationship 
appears fragile and providers worry about creating guilt and damaging trust. Discussing 
adherence with clients belonging to marginalized groups such as drug users, prisoners or 
ethnic minorities may be particularly complex and risky. As mentioned, they have generally 
more limited trust in providers (Pach, Cerbone, & Gerstein, 2003; Saha, Jacobs, Moore, & 
Beach, 2010;  Siegel, Karus, & Schrimshaw, 2000) and in the healthcare system (Pellowski, 
Price, Allen, Eaton & Kalichman, 2017). Moreover, when discussing the potential impact of 
‘deviant’ behaviours (e.g. substance abuse) on adherence, perceived moral judgements 
regarding such behaviours may compound those associated with non-adherence (de Kok, 
Laurier & Widdicombe, 2012).   
The dilemma of whether to trust or at least avoid questioning the client, or whether to 
probe their adherence, can be seen as part of a second, broader dilemma: the dual directive to 
achieve patient-centredness and public health targets (Watermeyer & Penn, 2012).  Providers 
are asked to be patient-centred and involve patients in decisions (BHIVA, 2016; WHO, 2016), 
seen in some contexts as patients’ (legal) right (e.g. in Scotland: the Patient Rights (Scotland) 
Act 2011). At the same time, professionals are expected to work towards public health targets, 
making adherence a priority. Several authors have argued that ART has led to a re-
medicalisation of HIV, with providers’ focus shifting from quality of life to treatment success, 
from personalized (palliative) care to technical monitoring of viral load, and from people to 
drugs (Rosengarten, Hart, Flowers & Imrie, 2004; Yallop et al. 2002). Tugenberg, Ware and 
Wyatt (2006) note providers’ sense of responsibility for clients’ adherence, fuelled by the 
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urgency of a deadly epidemic. This may explain observed provider responses to (suspected) 
poor adherence such as lecturing, becoming angry or shaming clients (op cit.), and more 
generally the paternalistic pursuit of compliance (Bader et al, 2006; Kremer et al., 2004). 
  For clients, however, social, psychological, or practical problems (e.g. poor mental 
health, homelessness) may trump adherence concerns.  Perceived differential priorities and 
the feeling that non-medical challenges are not legitimate issues to raise in consultations may 
obstruct discussion of adherence barriers (de Kok, Laurier & Widdicombe, 2012; Rosengarten 
et al., 2004). A further barrier to discussion of adherence problems is that clients fear 
providers’ disapproval, anger, or even loss of interest and care if not following ‘Doctor’s 
orders’ (Tugenberg et al. 2006, p. 271). Reluctance to share adherence difficulties may be 
enhanced, ironically, by providers’ emphasis on adherence and clients’ good relationship with 
their provider, whom they do not want to disappoint (Tugenberg et al., 2006; Yallop, Lowth, 
Fitzgerald, Reid  & Morelli, 2002). Yet, sharing adherence difficulties and beliefs about 
medication is central to adherence support (Poppa et al., 2004; Schneider et al., 2004) and 
shared decision-making.  
Various features of the disease and policy context therefore complicate patient-
centredness in adherence conversations. Moreover, providers’ sense of responsibility for, and 
emphasis on, clients’ adherence may not only be a barrier to patient-centredness and shared 
decision-making; it may introduce a third tension, between empowerment and 
responsibilisation.  
 In line with western, neo-liberal ideals of individual autonomy, patient-centredness 
and shared decision-making are often assumed to be desirable because they are ‘empowering’ 
(cf. Mol, 2008). Models, like the Healthcare Empowerment model, suggest that improved 
adherence will occur when patients are ‘empowered’ or engaged, informed, committed, 
collaborative and tolerant of uncertainty (Van den Berg et al., 2016).  However, sociological 
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and anthropological studies raise questions about the empowering effects of shared decision-
making, by illuminating how new forms of treatment like ART, and new treatment paradigms, 
change identities, social relationships, perceived rights and responsibilities. 
 Rosengarten et al. (2004) note how ART, like other medical technologies, has come to 
reveal new ‘truths’ about our bodies (e.g. CD 4 counts), triggering new obligations to self and 
others: keeping the viral load down (cf. Novas & Rose, 2000).  Providers and family members 
may expect that people living with HIV ‘work at’ staying well, and thus adhere, in return for 
their care (Ware et al. 2009). Kagee et al. (2014) note public health practitioners’ tendency to 
‘responsibilise’ HIV clients, by framing adherence as ‘prosocial behaviour’ which good 
citizens ought to perform to reduce the societal and health system burden. This sense of 
obligation to adhere is captured in Nguyen’s (2004) much used notion of ‘therapeutic 
citizenship’; a shared illness identity associated with rights (e.g. treatment access) and 
responsibilities (e.g. adherence). It appears then that by fulfilling a ‘duty’ to adhere, people 
living with HIV can maintain a moral identity (e.g. being a good and responsible client, 
relative, partner).  
  Specific forms of therapeutic citizenship will emerge from, and need to be examined 
in, specific historical, economic, socio-cultural and political contexts (cf. Nguyen, 2004).  We 
argue that currently, in HICs, therapeutic citizenship is shaped by the patient-centredness and 
shared decision-making paradigms. Participation in decision-making is a right, and an 
expectation of the ‘good’ patient. As Rapley (2008) notes, shared decision-making promotes 
new collaborative roles, which redistribute rights and responsibilities. Specifically, shared 
decision-making enables providers to share the burden and transfer some of their 
responsibility to clients. A provider in Rosengarten et al. (2004, p. 583) notes, talking about 
side effects ‘that you have induced’, that ‘discussing and letting them [patients] make 
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decisions (…)  are in part a way of reducing the em burdening guilt if something happens to 
go wrong’.    
  The new TasP paradigm may further increase responsibilisation. By widening the 
treatment remit to those not infected but at risk of HIV, TasP blurs distinctions between the 
identity categories ‘HIV positive’ and ‘HIV negative’, and modifies their associated 
responsibilities. Members of both categories are now obliged to avoid onward infection, and 
‘defaulters’ may be judged for increasing their sexual partners’ infection risks (Keogh & 
Dodds, 2015). Thus, we must examine how ‘biological citizens may be made increasingly 
responsible for more than their own health’ (Paperini & Rhodes, 2016, p. 514).  
  In summary, ART, and the paradigms of patient-centredness and shared decision-
making, do not merely empower patients; they produce new roles, rights and responsibilities 
for clients and providers. Clearly, ART and ART adherence support are not merely technical 
fixes but imbued with social meanings and moral dimensions. These dimensions are 
ultimately negotiated in the professional-client encounter, and it is to the details of 
communication in interaction that we now turn.   
 
 
3.4 Adherence talk and patient-centredness: The devil is in the interactional detail  
 
Understanding the aforementioned tensions and complexities requires a detailed examination 
of adherence talk and provider-client interaction. We need to see how providers actually ‘do’ 
trust, patient-centredness and shared decision-making: what conversational strategies do they 
use to display trust, enact principles of patient-centredness, and achieve shared decisions? 
How are the tensions and morality at play managed, how are responsibilities and entitlements 
negotiated and identities produced? Since most studies of ART communication use interviews 
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and surveys, they rely on providers’ and clients’ reports about communication rather than 
observations of actual interactions. Consequently, broad proxy operationalisations of patient-
centredness are common, such as agreement with the statement ‘My HIV provider really 
knows me as a person’ (Beach et al., 2006, p. 662).  These leave unexplored what 
communicative behaviours suggest to clients that they are known as a person. Some studies 
do suggest conversational strategies such as using individualized questions (Tugenberg et al., 
2006). However, without detailed analysis of their actual use, studies cannot demonstrate 
strategies’ effects, nor their likely contingency on when in the interaction strategies are used 
(Barton Laws et al., 2013b). The finding by Callon et al. (2016) that negatively-framed 
questions (e.g. ‘in the past three days would you say that you missed any of the dosages of 
your medicines?’) were 3.64 times more likely to elicit disclosure among non-adherent 
patients than other types of questions, underscores the importance of conversational details 
like the exact wording of questions. Finally, most studies focus solely on clients (Sankar, 
Golin, Simoni, Luborsky, & Pearson, 2006), rather than on the co-production of meaning and 
activities between client and provider.  
By contrast, joint activities and co-construction are central to our third body of 
literature: conversation analytic studies of practices used in communication between clients 
and health professionals (Heritage & Maynard, 2006). Conversation analysis examines the 
fine-grained turn-by-turn detail of naturally occurring talk-in-interaction to identify the 
underlying norms and practices that make those interactions orderly. For example, it examines 
how speakers take turns or remedy interactional problems; how speakers produce and 
recipients understand the actions brought about through talk; and how shared understanding is 
achieved (Sidnell, 2016). 
Early CA studies, pre-ART, examined interactions between HIV counsellors and 
clients, exploring the interactional strategies and devices used to discuss sensitive topics (e.g. 
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unsafe sex) in pre- and post-HIV test counselling, or to successfully deliver advice (Kinnell & 
Maynard, 1996; Silverman & Perakyla 1990; Perakyla & Silverman 1991). Sheon and Lee 
(2009) explored how counsellors and clients co-construct distrust and uncertainty regarding 
the partner’s disclosure of sero-status, and used their findings to develop training in HIV 
counselling. Watermeyer and Penn’s (2011, p.6) South African study shows how pharmacist 
assistants may pursue adherence by invoking a client’s identity as a community elder with 
associated responsibilities, or co-construct a client’s lack of motivation as basis for non-
adherence (‘maybe you take this as a game’; ‘tell us if not interested’).  This may lead to 
unhelpful and unfair responsibilisation, for instance when external contraints (e.g. financial) 
limit access to treatment. 
Furthermore, there is a growing body of CA research on choice, autonomy and shared 
decision-making in other healthcare contexts. This work demonstrates firstly that shared 
decision-making principles are not easily incorporated into all consultations about medicines. 
Collins et al.'s (2005) comparison of primary care diabetes consultations with secondary care 
oncology found a spectrum of practitioner approaches, ranging from unilateral to more 
bilateral. Through detailed sequential analysis, other CA work has shown that, with 
apparently more bilateral approaches, providers can still limit or expand choice (Pilnick et al., 
2004a, b; 2008; Toerien, Shaw & Reuber, 2013). For example, Pilnick (2004a, 2008) shows 
how providers’ perceptions that they are giving choices regarding antenatal screening for fetal 
abnormalities are not necessarily matched by clients’ experience. Even where practitioners 
endeavour to adopt patient-centred modes of interaction (for example by encouraging a client 
to set the agenda for a consultation), there are subtle ways in which choice and decision-
making can be undermined (e.g. Finlay, Walton & Antaki, 2008; Pilnick & Zayts, 2012; 
Toerien, Shaw & Reuber, 2013). Conversely, even where more unilateral approaches are 
used, clients can exert agency in subtle and implicit ways (Gill, 2005).    
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    CA studies of medical advice-giving illuminate how clients may resist and reject 
advice (Heritage & Sefi, 1992; Pilnick, 2003; Stivers, 2007), and how practitioners manage 
resistance to advice (Emmison, Butler & Danby 2011; Stivers, 2007). These studies show that 
direct advice risks being met with resistance. Unsolicited advice-giving can be seen as 
contrary to client-centredness and empowerment (Emmison, Butler & Danby, 2011), and as 
implicating criticism of clients (lack of) actions (Heritage & Sefi, 1992) or their lack of 
knowledge (Pilnick, 2003). More subtle forms of advice-giving may thus be more effective. 
For instance, Butler et al. (2010) show how child helpline counsellors manage the sensitivities 
of advice-giving by using ‘advice-implicative interrogatives’, which preserve the client’s 
authority to decide by presenting it in a question format.   
 Finally, CA studies have shed light on the management of responsibility  and morality 
in clinical encounters, describing for instance how practitioners can hold diabetic clients’ 
accountable for health-related actions  (Silverman, 1987), and how clients’ can perform moral 
work by downplaying their agency in treatment failure (Webb, 2009) and  framing themselves 
as ‘good patients’ (Pilnick & Coleman, 2003; Webb, 2009).     
  Taken together then, this third set of literature underscores that perceptions of 
communication (e.g. as being patient-centred) may differ from actual practices, and that there 
may be both more and less shared decision-making in ART discussions than surveys and 
interviews suggest. Furthermore, the CA literature begins to illuminate what concrete 
communicative strategies may be involved in of patient-centredness and shared decision 
making (cf. Watermeyer & Penn, 2011) and why the interactional, joint achievement of these 
principles is so complex. Finally, CA can elucidate how matters of morality and identity are 
managed through interaction. 
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4. Discussion 
 
In summary, psychological and public health studies indicate that provider-client relationships 
and communication are important for ART adherence and client satisfaction.  In particular, 
trust, patient-centredness and, to a lesser extent, shared decision-making are considered to be 
beneficial, but not always achieved. Drawing on anthropological and sociological studies, we 
suggested that this reflects tensions between doing patient-centredness (building trust, sharing 
decisions, empowering patients), and reaching public health targets, which in turn depends on 
probing adherence, ensuring desired decisions, and emphasising responsibilities.  These 
tensions are exacerbated by the particular infectious disease and policy context. 
  The CA literature demonstrated how fine-grained analysis of actual encounters can 
identify the subtle interactional practices involved in achieving patient-centredness and shared 
decision-making in practice. CA studies provide details of how, in interaction, through subtle 
features of what, how and when something is said, speakers can provide choices (or not), 
offer and resist advice effectively (or not). These techniques, we propose, are ideally suited to 
an analysis of the enactment of patient-centredness, shared decision-making and trust in ART 
encounters. CA can provide new insights into the management and resolution of the identified 
tensions, and illuminate the enactment of rights and responsibilities attached to new forms of 
therapeutic citizenship, which may well affect patient satisfaction.   
  Practically, providers have been given little guidance in terms of how to ‘do’ patient-
centredness and shared decision-making in ART adherence support (Watermeyer & Penn, 
2012). General guidelines for practitioners on implementing patient-centredness exist (see e.g. 
Mathhias et al 2013), but these neglect that interaction and thus patient-centrednesss or shared 
decision-making are joint activities. CA can help develop strategies which are grounded in 
this co-production, and so meet the calls for communication training (van den Berg et al., 
23 
 
2016; Wilson et al., 2010).  Whilst the evaluations of CA derived training programmes are 
still in their infancy, results suggest the potential to bring about changes in communication 
that are acceptable to both patients and practitioners (Heritage et al., 2007), seemingly 
because recommendations are rooted in observations of actual talk rather than abstract 
communication theories or models.  
Furthermore, the sociological and anthropological literature illuminated how patient-
centredness and shared decision-making may be empowering but can also entail problematic 
forms of responsibilisation. ART has generated new disease-based, moral identities, 
expectations, rights and responsibilities, which affect ART adherence and social relationships. 
Understanding how new forms of therapeutic citizenship are enacted interactionally 
constitutes a theoretical contribution to CA,  and the numerous anthropological and 
sociological studies of ART, which examine the socio-cultural, economic and political 
context, but rarely the details of the interactional context. We propose that CA studies engage 
to a greater extent with theoretical notions developed in the anthropological and sociological 
literature, and with terms and principles widely used and advocated in policy. Unpacking the 
interactional specifics of these notions and terms, will illuminate what these mean not only in 
theoretical terms but also as they are talked into being. 
This review has several implications for future studies of ART adherence.  They 
should include a variety of client groups, including those taking ART as prevention. TasP 
raises new questions, amidst worries that it proceeds without sufficient social science input 
(Keogh & Dodds, 2015). Given the increased vulnerability of marginalized patient groups 
(higher HIV infection rates; less benefit from ART, more loss to follow up (BHIVA, 2016)) 
and findings that interactions with ethnic minorities exhibited less shared decision-making 
(Barton Laws et al., 2014), it is important to examine whether and how communication may 
reflect and contribute to inequalities and marginalization (op cit.). Furthermore, studies should 
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study actual interaction, whilst also taking account of the broader social and policy context in 
which these interactions take place. Incorporating context in CA is not straightforward (de 
Kok, 2008), but important. Finally, we included a wide range of studies in terms of 
disciplinary orientation, epistemological and theoretical perspective, and methodology. 
Recording and synthesizing such a diverse set was challenging and time-consuming, but, 
importantly, it enabled us to enrich and go beyond the insights generated by any of the three 
separate sets.  Crucially, we applied insights from LMIC studies (e.g. regarding therapeutic 
citizenship) to HIC settings, which is rarely done: if scholars focus on both settings, the 
‘transfer’ is usually from HIC studies to LMIC studies.  More multidisciplinary, multi-context 
reviews should be conducted in the future, whether regarding ART adherence or other 
phenomena. 
 
Conclusion 
Supporting ART adherence amongst the growing and increasingly diverse client population 
remains important yet challenging. Getting HIV care and ART adherence support right is 
crucial for public health and social justice. Provider-client relationships and communication 
are undoubtedly important, but understanding whether, when and for whom patient-
centredness and shared decision-making are appropriate and feasible requires more detailed 
interactional studies which also acknowledge the broader social, relational and moral 
dimensions and effects of ART and ART communication. Further empirical studies which 
engage with, and integrate, the three literatures reviewed should produce actionable insights 
which can inform training and policy, leading to better quality professional adherence 
support.  
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